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Abstract  
AIM: This study was to assess the prophylactic and curative effects of Essentiale forte (ESF) on 
carbon tetrachloride (CCl4) induced liver damage in Wistar rats.  
MATERIALS AND METHODS: Twenty-four adult Wistar rats were randomly divided into four 
groups of six rats each. Group I (control group) received 0.3 ml/kg/day of propylene glycol for one 
month; group II (toxic control) was given 0.7 ml/kg/day of CCl4 dissolved in olive oil (1:1,v/v) orally 
for 7 days; group III (prophylactic group) received 4.3 mg/kg/day of ESF for one month followed by 
CCl4 for one week; group IV (curative group) was treated with CCl4 for one week and subsequently 
received ESF (4.3 mg/kg/day) for one month. Half of the rats were sacrificed at active period, the 
other half after a 2-week recovery period. 
RESULTS: The activities of serum AST, ALT, ALP, total bilirubin level were significantly higher, 
total protein and GSH levels were significantly reduced in the toxic control group compared to the 
control group. Group III had significantly higher AST and ALT activities compared to the control rats 
at active period, whereas after the recovery period no significant differences were observed in 
almost all the parameters. Moreover, no significant differences in the parameters mentioned above 
were observed in group IV compared to the control rats at active and recovery period. 
CONCLUSION: The results of this study showed that Essential forte was better as a curative agent 
rather than a prophylactic agent in rats. 
 
 
 
 
 
 
 
 
Introduction 
Hepatotoxicity is defined as an injury to the 
liver that is associated with impaired liver function 
caused by exposure to a drug or another non-
infectious agent [1]. 
 Hepatotoxic agents like chemicals, drugs, and 
pesticides are usually encountered by man due to job 
demands or habits. The incident of liver diseases is on 
the increase worldwide. The consequences of the 
toxicity inflicted on the liver by hepatotoxic substances 
are very grave and constituting a sort of concern for 
scientist globally [2]. Liver diseases and even their 
management methods represent a major global health 
problem [3]. Toxic chemicals, xenobiotics, alcohol, 
malnutrition [4], viral and microbial infections are 
harmful to the liver cells. 
 Essentiale forte (ESF) is a hepatoprotective 
drug that has been reported to protect and improve 
liver function in diabetic subjects with nonalcoholic 
fatty liver [5] and chronic infections. It basically 
contains phospholipids from soya-beans, soya-bean 
oil, hydrogenated castor oil, ethanol, ethyl vanillin, 4-
methoxyacetophenone, gelatin colouring agents 
E171, E172, DL-α- tocopherol.  It is also used to treat 
hepatic cirrhosis, necrosis of the liver cells, liver 
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failure, liver coma, diseases of the cardiovascular 
system, hyperlipoproteinemia, hypercholesterolemia, 
atopic dermatitis, eczema, pyelonephritis [6]. Most of 
the reported studies on ESF were on human subjects. 
Studies on animal models of liver damage is also 
worth embarking upon in view of the fact that animals 
also suffer from liver ailments just like man and also 
that information derived from animals studies using 
the drug could add to the body of the existing 
knowledge on the use of the drug in the treatment 
liver diseases. We therefore decided to assess the 
curative and prophylactic effects of ESF on carbon 
tetrachloride-induced liver damage in Wistar rats, with 
a view to providing additional scientific information on 
the suitability of the drug in the treatment of liver 
diseases.   
 
Materials and Methods 
Animal care and management 
Twenty- four adult Wistar rats weighing 150 g 
- 200 g that were used in this study were obtained 
from the Animal House of the College of Health 
Sciences, Obafemi Awolowo University, Ile-Ife, 
Nigeria. The rats were kept under normal 
environmental conditions with a 12/12 h light/dark 
cycle and had free access to standard rodent pellet 
diet (Caps Feed PLC, Osogbo, Nigeria) and water ad 
libitum. They were allowed to acclimatize in the 
laboratory for 2 weeks before the commencement of 
the study. The experimental procedures adopted in 
this study were in strict compliance with the guidelines 
on Experimental Animal Care and Use of Laboratory 
Animals in Biomedical Research, College of Health 
Sciences, Obafemi Awolowo University, Ile-Ife, 
Nigeria. 
 
Drugs and chemicals 
Essentiale forte
®
 was from (A. Natterman and 
Cie GmbH (Germany). Ltd; batch number 10091); 
carbon tetrachloride from Hopkins and Williams 
(Birmingham, England, UK), and propylene glycol 
from (Biovision, Milpitas, CA, USA). 
 
Drug preparation 
Each capsule contains 300 mg of ESF. One 
capsule was dissolved in 20 ml of propylene glycol. 
Therefore, 0.04 ml of the solution equivalent to 0.64 
mg of ESF was administered to a rat 150 g orally 
(p.o.); this is equivalent to 4.3 mg/kg, which is the 
therapeutic dose of the drug in humans.  
 
Experimental design 
 The rats were randomly divided into four 
groups of six rats each. The rats were treated as  
follows: group I (control group received 0.3 ml/kg/day 
of propylene glycol, the vehicle in which ESF was 
dissolved, orally for one month); group II (toxic 
control) was given 0.7 ml/kg/day of carbon-
tetrachloride (CCl4) dissolved in olive oil (1:1,v/v) 
orally for 7 days so as to induce liver damage [7]; 
group III (prophylactic group) received 4.3 mg/kg/day 
of ESF orally for one month and subsequently CCl4 
(0.7 ml/kg/day) was administered for one week; group 
IV (curative group) was given CCl4 (0.7 ml/kg/day) for 
one week and subsequently received 4.3 mg/kg/day 
of ESF orally for one month.  
A day after the last dose of ESF, CCl4 and 
propylene glycol as the case may be for each group, 
three of the rats in each group were sacrificed under 
chloroform anaesthesia and their blood was obtained 
by cardiac puncture and drawn into separate plain 
bottles. The blood was centrifuged for 15 mins at 4000 
rpm using a bench centrifuge. The serum was 
separated and analyzed for the liver enzymes and 
other organic constituents that are routinely used in 
the assessment of liver function. Thereafter, the liver 
of each rat was carefully excised for weight 
determination. Portion of the liver was homogenized 
and centrifuged at 4000 rpm for 30 mins to yield a 
clear supernatant fraction that was used for reduced 
glutathione (GSH) analysis, while the remaining part 
was fixed in 10% formo-saline for histopathological 
studies. The remaining three rats in each group were 
left for a two week recovery period before they were 
sacrificed using the same procedure and the same 
parameters were measured. The entire treatment 
procedure was summarized in Table 1. 
  Table 1: Treatment procedure is as shown below: 
 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 
Group 1 PG PG PG PG
* 
RP RP
** 
 
Group 2 CCl4
* 
RP RP
** 
    
Group 3 ESF ESF ESF ESF CCl4
* 
RP
 
RP
** 
Group 4 CCl4 ESF ESF ESF ESF
* 
RP RP
** 
PG = Propylene glycol  (0.3 ml/kg/day); CCl4 = Carbon tetrachloride (0.7 ml/kg/day); ESF = 
Essentiale forte (4.3 mg/kg/day); RP = Recovery period; * =  Point of sacrifice of the first 
half of the group; ** = Point of sacrifice of the second half of the group. 
 
Measurement of body weight 
The body weight of the animals were 
measured once in a week using a (Camry; Zhongshan 
Guangdong, China) during the experiment to access 
the weight gain or loss in each group. 
 
Measurement of food consumption and water 
intake 
The food consumption and water intake of the 
animals were determined daily from the onset of the 
experiment. The volume of water and weight of food 
given to each group of rats were measured with a 
measuring cylinder and a weighing balance 
respectively. The difference between the previous day 
volume of water and weight of food and the left-over 
was taken as the daily food consumption and water 
intake of the group. 
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Biochemical analysis 
Levels of aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), alkaline phosphatase 
(ALP), total bilirubin, total cholesterol and serum 
glucose were assayed by the use of appropriate 
biochemical kits purchased from Randox Laboratories 
(Crumlin, Co. Antrim UK)  
Total protein (TP) was assayed in the serum 
according to the method of Bradford [8]. 
Reduced glutathione (GSH) assay was 
carried out in liver tissue homogenate according to the 
method of Tietze [9]. 
 
Histopathological evaluation 
 The fixed liver samples were dehydrated in 
graded alcohol and embedded in paraffin wax. They 
were then cut into 4-5 μm thick sections and stained 
with haematoxylin-eosin for photomicroscopic 
assessment using a Leica DM 750 Camera 
Microscope at x400 magnification. 
 
Statistical analysis  
The results obtained were expressed as 
mean ± SEM. The data were analyzed using One-way 
ANOVA followed by Tukey’s multiple comparison tests 
using GraphPad 5.03 (GraphPad Software Inc., CA, 
USA). The results were considered significant when p 
< 0.05. 
 
Results 
             Food and water consumption 
 The toxic control showed a significant 
decrease in water intake compared to the control (p < 
0.05) at active and recovery period (Table 2).  
Also, there was a significant decrease in food 
and water consumption in the prophylactic group 
compared to the control (p <0.05) at recovery period. 
A significant decrease in water intake was observed in 
the curative group compared to the control and 
prophylactic group at active period, but no significant 
difference from the control at recovery period.  
 
Table 2: Food consumption, water intake, liver weight and reduced glutathione at active and recovery period. 
 
            Food Consumption (g)             Water Intake (ml)                                 Liver weight (g)                        Reduced glutathione (U/ml) 
 Active                Recovery period Active  Recovery period    Active        Recovery period         Active             Recovery period 
Control (n=3,3) 15.08 ± 2.43 17.86 ± 5.16 24.53 ± 2.81 31.43 ± 4.30           3.53 ± 0.08      3.42 ± 0.03            2.43 ± 0.56       2.46 ± 0.58         
Toxic control (n=3,3) 14.05 ± 5.08                    16.07 ± 2.89 18.14 ± 5.38
*
 23.93 ± 2.50
*
          4.53 ± 0.33
*
     4.21 ± 0.43
*  
         0.61 ± 0.27
*
      1.64 ± 0.25
* 
Prophylactic (n=3,3) 14.74 ± 2.15                   13.33 ± 3.98
*#
 24.46 ± 4.27
a#
 25.36 ± 5.32
*
          3.94 ± 0.28      3.33 ± 0.10
a
          1.72 ± 0.24
a
       2.74 ± 0.46
a 
Curative (n=3,3) 16.14 ± 3.08 17.98 ± 6.20 21.03 ± 3.49
*
 30.21 ± 5.38
a
          3.90 ± 0.16      3.50 ± 0.33
a
          2.25 ± 0.08
a
       2.17 ± 0.70
a 
Significantly different from 
*
control, 
a
toxic control , and from 
#
curative group. Values are mean ± SEM. 
 
 
 
Liver weight and reduced glutathione 
There was a significant increase in the 
relative liver weight of the toxic control compared to 
the control (p < 0.05) at active and recovery period 
(Table 2). The GSH level in the treated groups was 
significantly higher than in the toxic control with values 
being comparable and not significantly different from 
the control (p > 0.05) at active and recovery period 
(Table 2). 
 
Serum biochemical parameters  
The activities of serum AST, ALT, ALP and 
total bilirubin level were significantly elevated in the 
toxic control compared to the control at active period 
(Table 3). An increase in total cholesterol level was 
also seen in the toxic control group but not 
significantly different from the control (Table 3). Also, 
there were significant reductions in total protein, 
serum glucose (Table 3) and glutathione activity 
(Table 2) in the toxic control compared to the control 
(p < 0.05) at active period. 
 The activity of AST, ALT and ALP activities 
were also found to be significantly increased in the 
prophylactic group when compared to the control (p > 
0.05) at active period (Table 3). On the other hand, 
there were no significant differences in ALT and AST 
activities of this group compared to the negative 
control (p > 0.05) at recovery period (Table 4). The 
curative group showed significant reductions in AST, 
ALT and ALP activities (p < 0.05) when compared to 
the toxic control at active period (Table 3). However, 
activities of AST and ALP in the curative group were 
significantly higher than the control, lower but not 
significantly different from that of the toxic control at 
recovery period (Table 4). 
 
Liver weight and reduced glutathione activity   
The prophylactic group showed significant 
decrease in glucose level compared to the control and 
curative group (p <0.05) at active period. However, 
there was a significant increase in the serum glucose 
level of curative group compared to the toxic control (p 
> 0.05) with value being comparable and not 
significantly different from the control at active period 
(Table 4).  
As shown in Table 4, there were no significant 
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Table 3:  Serum biochemical parameters at active period.   
                                        ALT 
                                        (U/L) 
       AST                            ALP                     TB                          TP                          SG                         TC 
       (U/L)                           (U/L)                 (μmol/l)                  (mg/ml)                  (mg/dl)                  (mmol/l) 
Control                      23.50 ± 6.36  25.00 ± 8.46              47.50 ± 3.54           3.50 ± 2.12            1.45 ± 0.02          119.0 ± 5.66           1.17 ± 0.27 
Toxic control           106.33 ± 29.94 
 
 96.00 ± 11.27
*
         657.2 ± 42.03
* 
       20.00 ± 5.00
*
            1.27 ± 0.02
*
          73.80 ± 21.40
*
       1.50 ± 0.32 
 
Prophylactic              84.50 ± 7.78
*#
  77.50 ± 19.09
*#
       575.2 ± 105.70
*#
       5.00 ± 0.14
a                
1.48 ± 0.01
a               
63.20 ± 1.41
*#           
1.24 ± 0.08 
Curative                     22.00 ± 1.41
a 
 33.50 ± 3.54
a
            82.88 ± 23.31
a
        5.65 ± 0.92
a                
1.45 ± 0.03
a
        136.60 ± 31.16
a
       1.08 ± 0.19
a
  
  
ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; TB, total bilirubin; TP, total protein; SG, serum glucose; TC, total cholesterol. Significantly 
different from 
*
control, 
a
toxic control, and from 
#
curative group. Values are mean ± SEM. (n = 3). 
 
differences in total bilirubin, total cholesterol, serum 
glucose and total protein levels of the treated groups 
and toxic control compared to the control (p > 0.05) at 
recovery period. 
 
Body weight 
A significant decrease in body weight was 
observed in the prophylactic group when compared to 
the control (p<0.05) at recovery period, as shown in 
Figure 1. 
 
Table 4:  Serum biochemical parameters at recovery period 
 ALT 
(U/L) 
AST 
(U/L) 
ALP 
(U/L) 
TB 
(μmol/l) 
TP 
(mg/ml) 
SG 
(mg/dl) 
TC 
(mmol/l) 
Control 26.00 ± 4.24 28.00 ± 12.73  99.85 ± 1.73 4.35 ± 1.20 1.45 ± 0.03 118.6 ± 13.63 1.18 ± 0.15 
Toxic control  32.00 ± 26.66 60.00 ± 8.54
*
 715.6 ± 140.0
*
        5.67 ± 1.53       1.48 ± 0.01  120.51 ± 10.74       1.50 ± 1.60 
Prophylactic 22.00 ± 1.41 21.50 ± 2.12
a#
 185.0 ± 14.14
*a
    5.80 ± 0.85  1.38 ± 0.07   88.00 ± 18.38   1.32 ± 0.02 
Curative 22.50 ± 4.24 54.00 ± 18.38
*
 482.0 ± 164.0
*a
     4.30 ± 1.84 1.43 ± 0.01   93.92 ± 22.18       1.15 ± 0.06 
ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; TB, total bilirubin; TP, total protein; SG, serum glucose; TC, total cholesterol. Significantly 
different from 
*
control, 
a
toxic control, and from 
#
curative group. Values are mean ± SEM. (n = 3). 
 
Histomorphological observations  
Liver 
The liver section of toxic control rats shows 
distortion of the normal hepatic cells arrangement with 
few perivascular vacuole (Figure 3) compared to the 
control which shows normal hepatic cells with well-
preserved cytoplasm and prominent nucleus (Figure 
2). The curative group shows well-preserved 
hepatocytes which are arranged normally (Figure 5) 
compared to the toxic control, while prophylactic 
group appears necrotic with distortion of hepatic cells 
(Figure 4) compared to the control and curative group 
at active period. 
 
Figure 1: Mean body weights of rats. *significantly different from 
control at p < 0.05. 
# 
significantly different from curative group at p < 
0.05. 
The liver section of toxic control shows 
distortion of hepatic cells with slightly ballooned 
sinusoid (Figure 7) compared to the control which 
shows normal hepatic cells with distinct and intact 
central vein (Figure 6). The prophylactic group shows 
restoration of the normal architecture of the liver as a 
result of tissue regeneration (Figure 8) compared to 
the toxic control. Similarly, curative group shows 
appreciable tissue regeneration of the hepatic cells 
(Figure 9) when compared to the toxic control at 
recovery period.  
 
Figure 2: Liver section of control rats sacrificed at active period 
showing normal hepatocytes with well-preserved cytoplasm and 
prominent nucleus. The portal vein, hepatic artery, interlobular bile 
duct are well-defined. 
 
Discussion  
Carbon-tetrachloride has been reported to 
have deleterious effects on the brain of rats [10]. 
Thus, the significant decrease in water intake 
observed in the toxic control group and group 
prophylactically treated with the drug maybe as a 
result of depression of thirst center located in the 
lateral hypothalamus [11] by CCl4. However, this 
needs further verification.  
The significant decrease in food consumption 
in the prophylactic group compared to the control at 
recovery period maybe as a result of stupor observed 
in this group during the period of CCl4 administration. 
Similarly, the significant decrease in body weight seen 
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in the prophylactic group when compared to the 
control group could be ascribed to the decrease in 
food consumption observed in this group. 
 
Figure 3: Liver section of toxic control rats sacrificed at active period 
showing distortion in the arrangement of the hepatic cells with few 
perivascular vacuole (arrow). 
There was a significant increase in enzyme 
activities of the liver transaminases in the toxic control 
group, relative to the control group. This may be an 
indication of cellular leakages and loss of the 
functional integrity of the cell membranes in the liver 
which is always associated with hepatonecrosis [12, 
13]. The results of the present study indicated that the 
liver cells of the toxic control group had been 
damaged by CCl4 as evidenced by the 
photomicrograph in Figure. 3. The curative group 
showed a significant reduction in the activities of the 
transaminases compared to the toxic control group, 
while the prophylactic group had high activities of the 
enzymes which were not significantly different from 
the toxic control group in rats that were sacrificed a 
day after the last dose of CCl4. The significant 
decrease in enzyme activities of the liver 
transaminases in the curative group is an indication of 
stabilization of plasma membrane as well as repair of 
hepatic tissue damage caused by CCl4. This is 
supported by the view that serum activities of the 
transaminases return to normal with the healing of 
hepatic parenchymal and regeneration of hepatocytes 
[14].  
 
Figure 4: Liver section of prophylactic group sacrificed at active 
period showing distortion of cellular arrangement, cellular 
boundaries are obliterated. Some hepatic cells appear degenerating 
(asterisk). 
 
Figure 5: Liver section of curative group sacrificed at active period 
showing normal hepatic cells and sinusoid (S).  
Polyenylphosphatidylcholine (PPC) is a class 
of phospholipids that is known to protect the liver 
through the regeneration of liver cells [15]. Therefore, 
the decrease in enzyme activities of the 
transaminases in the curative group could be 
attributed to PPC present in ESF. This assertion is 
also corroborated by the representative liver 
photomicrograph of rats in this group (Figure 5). The 
prophylactic group showed a decrease in the activities 
of the enzymes that were not significantly different 
from that of the toxic control group. It might be that 
PPC contained in ESF does not make the 
hepatocytes resilient to toxic effect of CCl4 as much as 
it facilitates regeneration resulting from hepatotoxin. 
The photomicrograph of this group is a proof to this 
affirmation as it appeared more necrotic than that of 
the curative group (Figure 4).   
 
Figure 6: Liver section of control rats sacrificed after the recovery 
period showing the central vein which is distinct and intact. 
Hepatocytes appear normal with intact cytoplasm. The sinusoids 
are normal in size, shape and number and well demarcated. 
The activity of AST in group IV was 
significantly higher than the control group, lower but 
not significantly different from that of the toxic control 
at recovery period. The photomicrograph of the liver of 
this group showed appreciable tissue regeneration. 
The later upsurge in the activity of AST in this group 
may be extrahepatic in origin perhaps as a result of 
leakages from damaged or necrotic tissues of the 
heart, skeletal muscles and kidneys [16, 17]. There 
was no significant difference in the activity of ALT in 
the treated groups compared to the control group at 
recovery period, due to healing of hepatic 
parenchymal and regeneration of hepatocytes. 
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Figure 7: Liver section of toxic control rats sacrificed after the 
recovery period showing slightly ballooned sinusoids with distortion 
of hepatic cells. Perivascular vacuole (arrow) are present but not 
prominent. 
The activity of alkaline phosphatase (ALP) 
was significantly higher in the toxic control group than 
in the control rats as a result of CCl4 induced liver 
damage. Alkaline phosphatase is excreted normally 
via bile by the liver. In liver injury due to hepatotoxic 
substances, there is a defective excretion of the bile 
by the liver, causing increased ALP activity in the 
serum [18]. The activity of ALP was significantly lower 
in the curative group than in the toxic control group. 
Treatment with ESF suppressed the increased activity 
of ALP in the serum. In the prophylactic group, the 
activity of this enzyme was not significantly different 
from the toxic control, indicating that ESF was not 
able to prevent the cells of the liver from being 
damaged by CCl4. 
 
Figure 8: Liver section of prophylactic group sacrificed after the 
recovery period showing normal hepatic cells arranged in plate. 
Hepatic vein appears normal. 
  ALP activity in the treated groups was 
significantly higher than the control group but 
significantly lower than the toxic control at recovery 
period. This suggests that CCl4 may be inducing the 
synthesis of ALP in other organs but possibly at a 
slow rate.  
Similarly, total bilirubin level was significantly 
increased in the toxic control group compared to the 
control group at active period may have resulted from 
the inability of the liver to metabolized and then 
excrete bilirubin through the bile ducts and gallbladder 
into the intestine indicating a possible hepatic injury. 
The bilirubin level in both the curative and prophylactic 
groups were not significantly different from the control 
group in rats that were sacrificed after the last dose of 
ESF and CCl4 as the case may be for each group. 
The reduction in bilirubin level in the treated groups in 
rats that were sacrificed after the recovery period is a 
strong indication of restoring normal liver function. 
 
Figure 9: Liver section of curative group sacrificed after the recovery 
period showing normal hepatocytes. Sinusoids (S) appear slightly 
dilated. 
There was a significant decrease in total 
protein in the toxic control group compared to the 
control group and treated groups at active period. This 
may be due to defects in protein biosynthesis as well 
as disruption and dissociation of polyribosomes from 
endoplasmic reticulum following administration of CCl4 
[19]. The increase in total protein level in the treated 
groups relative to the toxic control group could have 
been due to the promotion of ribosome assembly on 
endoplasmic reticulum which facilitates uninterrupted 
protein biosynthesis [13]. 
The observed increase in cholesterol level 
may have resulted from damage to hepatic 
parenchymal cells that lead to disruption of lipid 
metabolism in the liver [20]. There was a significant 
decrease in total cholesterol level of the treated 
groups compared to the toxic control group, because 
ESF has been reportedly used in the treatment of 
hypercholesterolemia [6] . 
 The serum glucose level also dropped 
significantly in the toxic control group compared to the 
control group at active period. This could be due to 
decreased hepatic glycogen content after treatment 
with CCl4, reflecting decreased gluconeogenesis by 
the liver [21]. The significant decrease in the serum 
glucose level observed in the prophylactic group may 
have resulted from decreased food consumption 
observed in this group, more so as the 
photomicrograph of the liver of this group showed 
appreciable tissue regeneration of the hepatocytes 
(Figure 8).  
The toxic control group showed a significant 
increase in the relative liver weight compared to the 
control group. This may have resulted from 
inflammation in response to injury caused by CCl4 or 
reduction in protein causing rapid mitosis of the 
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hepatic cells and growth of the liver to a larger size 
[11]. 
 The glutathione (GSH) level in the toxic 
control group was significantly lower than in the 
control and treated groups. Administration of CCl4 to 
rats in order to induce liver damage resulted in 
decreased level of glutathione (GSH) [22]. The 
observed decrease in GSH activity in the toxic control 
group could be attributed to increased use of GSH in 
preventing damage to important cellular components 
caused by reactive oxygen species such as free 
radicals and peroxides [23]. The significant increase in 
GSH level, both in the curative and prophylactic 
groups could be ascribed to the presence of vitamin E 
in ESF. Vitamin E has been reported to protect the 
polyunsaturated fatty acids of cellular membranes and 
low-density lipoproteins (LDL) from oxidative damage 
caused by free radicals. In this manner, vitamin E 
serves to protect and stabilize the cellular membrane 
through its role as a powerful antioxidant [24]. 
In conclusion, the results of the study showed 
that ESF do not have much membrane stabilizing 
properties as they facilitate regeneration of the 
hepatocytes when used as remedies against 
hepatotoxic substances. 
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